Ishita Drugs & Industries Ltd.

BSE: ISHITADR · Pharmaceuticals · sector

₹70.53BSE close 2026-10-26

Key numbers

Market cap₹21 cr

Price₹70.53

52w high / low₹91 / ₹66

P/E29.9xSector median 27.9x

P/B1.8xSector median 2.9x

Book value₹38.7

Dividend yield–Sector median 0.48%

ROE6.3%Sector median 11.7%

ROCE8.9%Sector median 12.3%

OPM5.9%Sector median 14.0%

Debt / equity0.01xSector median 0.16x

EV/EBITDA19.4xSector median 18.6x

Interest cover25.5x

Current ratio9.65x

Sales growth 3y+6.7%Sector median +9.6%

Profit growth 3y+10.3%Sector median +13.3%

PEG2.86x

Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 185 companies in Pharmaceuticals (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Cash ₹7 cr vs borrowings ₹0 cr (FY26): cash is higher (net cash).
Operating profit covered interest 25.5x in the last 12 months.
Other income was 59% of net profit in the last 12 months.
No dividend in the last 5 financial years.
Price ₹70.53 on 2026-10-26: -22.4% from the 52-week high, +6.9% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹96.35 · low ₹70.00

Quarterly results

₹ cr	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	5	5	3	3	3	3
EBITDA	0	0	0	0	0	0
OPM %	6.4%	6.5%	6.2%	4.5%	2.9%	10.2%
Other income	0	0	0	0	0	0
Net profit	0	0	0	0	0	0
EPS (₹)	0.96	1.01	0.48	0.52	0.59	0.77
Revenue YoY					-32.9%	-41.7%
Profit YoY					-37.9%	-23.3%

Standalone figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ cr	FY22	FY23	FY24	FY25	FY26	TTM
Revenue	14	12	15	15	15	12
EBITDA	1	1	1	1	1	1
Net profit	1	1	1	1	1	1
EPS (₹)	2.69	1.93	2.50	2.90	2.60	2.36
Revenue growth		-14.3%	+25.8%	-1.3%	-2.3%	–
Profit growth		-28.4%	+29.3%	+16.0%	-10.3%	–
Dividend / share (₹)	–	–	–	–	–

Compounded growth	3 years	5 years	Last 12 months
Sales	+6.7%	–	–
Net profit	+10.3%	–	–
EPS	+10.4%	–	–
Share price	–	-3.6% (2y)	-2.0%

Balance sheet

₹ cr	FY25	FY26
Shareholders' equity	11	12
Borrowings	4	0
Cash & equivalents	8	7
Total assets	16	13
Fixed assets	1	1
Capital work in progress	0	2
Investments	0	0
Receivables	2	1
Inventory	4	1
Payables	1	1

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY25	FY26
Cash from operations	-4	4
Cash from investing	-1	-2
Cash from financing	4	-4
Capex	0	2
Free cash flow	-4	2

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY25	FY26
ROE %	8.0%	6.7%
ROCE %	8.4%	9.8%
Debtor days	46	25
Inventory days	153	33
Payable days	32	20
Cash conversion cycle (days)	167	38
Working capital days	233	213

Peers in Pharmaceuticals

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
SUNPHARMA	₹4,17,478 cr	34.5x	5.0x	15.5%	18.7%	28.6%	+10.0%	0.94%
DIVISLAB	₹2,39,825 cr	82.1x	14.3x	18.4%	23.0%	34.7%	+10.8%	0.34%
TORNTPHARM	₹1,53,999 cr	72.7x	18.4x	27.3%	15.1%	32.3%	+13.3%	0.84%
ZYDUSLIFE	₹1,15,808 cr	25.9x	4.3x	17.7%	16.8%	27.2%	+16.4%	0.95%
LAURUSLABS	₹1,11,232 cr	101.6x	21.0x	22.4%	20.8%	28.0%	+4.1%	0.08%
CIPLA	₹1,09,464 cr	32.5x	3.2x	10.3%	13.2%	17.7%	+7.4%	1.18%
DRREDDY	₹1,09,460 cr	33.9x	2.9x	9.0%	10.1%	15.5%	+11.0%	0.61%
MANKIND	₹95,486 cr	46.7x	5.9x	13.4%	13.8%	25.1%	+17.7%	0.04%
AUROPHARMA	₹91,489 cr	24.9x	2.4x	10.5%	12.8%	20.0%	+10.6%	0.26%
ISHITADR	₹21 cr	29.9x	1.8x	6.3%	8.9%	5.9%	+6.7%	–

All 185 companies in Pharmaceuticals →

Dividends & corporate actions

Ex-date	Action	Detail
2001-09-10	Dividend	NIL Dividend

Documents

Links go to the original files on the exchange website.

About the company


Sector	Healthcare
Industry	Pharmaceuticals
Sub-industry	Pharmaceuticals
Symbol	ISHITADR
BSE code	524400
ISIN	INE806D01016
Face value	₹10.0
Incorporated	–
Website	–
Plants (India / abroad)	–

Data built 2026-10-24 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.